Abiopharma

New Form 8-K - Lyra Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-107339 Size: 10 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits